Wednesday, June 10, 2026

Patent intelligence · EP

EP 1526849

TOPISCHE ZUSAMMENSETZUNG ENTHALTEND KETOPROFEN STABILISIERT MIT SULISOBENZON

expired A61K 31/ 19 A IA61K/3119A61K31/19A61P 29/ 00 A I
Status expired
Linked drugs 1
Pipeline programs 2
Years to expiry 0
Applicant portfolio 5
Patent details — EP 1526849
Jurisdiction
EP
Status
expired
Grant date
May 4, 2005
Expiration
Apr 29, 2025
CPC classes
A61K 31/ 19 A I, A61K/3119, A61K31/19, A61P 29/ 00 A I
View on Google Patents ↗

Quick answer

EP 1526849 (TOPISCHE ZUSAMMENSETZUNG ENTHALTEND KETOPROFEN STABILISIERT MIT SULISOBENZON) is held by MENARINI FARMA IND [IT]. Status: expired. Granted May 4, 2005. Expires Apr 29, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
CPC classes
A61K 31/ 19 A I, A61K/3119, A61K31/19, A61P 29/ 00 A I, A61P/2900, A61P29/00

More from MENARINI FARMA IND [IT]

Related pharmaceutical patents in our USPTO index.

  1. IT 201700031902

    Composizione nutraceutica, dietetica e nutrizionale ad attività antiossidante.

    A MENARINI IND FARMACEUTICHE RIUNITE S R L · Expires Sep 18, 2038

    granted
  2. CA 2682039

    PREPARATIONS COSMETIQUES VISANT A REDUIRE LA CELLULITE DISGRACIEUSE

    MENARINI FARMA IND [IT] · Expires Sep 27, 2028

    granted
  3. AT E203027

    PENEMDERIVATE, DEREN HERSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

    MENARINI FARMA IND [IT] · Expires Jul 10, 2021

    expired
  4. US 6150325

    Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical compositions

    MENARINI FARMA IND [IT] · Expires Nov 16, 2020

    expired

Frequently asked questions

What is US patent 1526849?

EP 1526849 (TOPISCHE ZUSAMMENSETZUNG ENTHALTEND KETOPROFEN STABILISIERT MIT SULISOBENZON) is held by MENARINI FARMA IND [IT]. Status: expired. Granted May 4, 2005. Expires Apr 29, 2025 (0 years remaining) — relevant for patent-cliff and LOE planning.

Who owns EP 1526849?

MENARINI FARMA IND [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 5 pharmaceutical patents for this assignee.

When does EP 1526849 expire?

Our index shows an expiration date of Apr 29, 2025 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.